C 20 H 23 N 3 O5S, monoclinic, P21/c (no. 14), a = 6.7503(2) Å, b = 14.0026(7) Å, c = 21.954(1) Å, β = 96.892(3)°, V =
T = 100 K.
CCDC no.: 1468116
The asymmetric unit of the title crystal structure is shown in the gure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters. 
. 
Experimental details
Carbon-bound H atoms were placed in calculated positions (C-H 0.95 Å) and were included in the re nement in the riding model approximation, with U iso (H) set to 1.2Ueq(C). The H atoms of the methyl groups were allowed to rotate with a xed angle about the C-C bond to best t the experimental electron density, with U iso (H) set to 1.5Ueq(C).
Discussion
Attributable to the extensive applicability of benzenesulfonamides, it is sought-after to acquire universal and successful methods for their production. Benzene-sulfonamides were the primarily drugs essentially a anced and increasingly used for demand and chemotherapeutic agents hostile to an assortment of diseases [1] . Greater than thirty drugs having this functionality are in quanti able utilize, including antiseptic [2, 3] , and extra biological activities [4] [5] [6] [7] [8] . Particular vital benzene-sulfonamide derivatives are used for instance carbonic anhydrase inhibitors of gainful magnitude [9] . A dumpy period ahead, benzenesulfonamides are registered as an anticancer proxies [10] . In persistence of our marvel in the synthesis of talented heterocyclic compounds [11] [12] [13] , we testimony here a novel 4-((4,4-dimethyl-2,6-dioxocyclohexylidine)methylamino)-N- 
